157 related articles for article (PubMed ID: 19793997)
1. Insulin response in relation to insulin sensitivity: an appropriate beta-cell response in black South African women: response to Goedecke et al.
Joffe BI; Distiller LA
Diabetes Care; 2009 Oct; 32(10):e123; author reply e124. PubMed ID: 19793997
[No Abstract] [Full Text] [Related]
2. Insulin response in relation to insulin sensitivity: an appropriate beta-cell response in black South African women.
Goedecke JH; Dave JA; Faulenbach MV; Utzschneider KM; Lambert EV; West S; Collins M; Olsson T; Walker BR; Seckl JR; Kahn SE; Levitt NS
Diabetes Care; 2009 May; 32(5):860-5. PubMed ID: 19196884
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic β cells: Gatekeepers of type 2 diabetes.
Park YJ; Woo M
J Cell Biol; 2019 Apr; 218(4):1094-1095. PubMed ID: 30696700
[TBL] [Abstract][Full Text] [Related]
4. Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control.
Marchetti P; Lupi R; Del Guerra S; Bugliani M; D'Aleo V; Occhipinti M; Boggi U; Marselli L; Masini M
Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S178-83. PubMed ID: 19875548
[No Abstract] [Full Text] [Related]
5. Beta-Cell Function and Its Underlying Mechanism 2015.
Li Y; Wang C; Omar B; Chen L
J Diabetes Res; 2016; 2016():7638120. PubMed ID: 26783538
[No Abstract] [Full Text] [Related]
6. Sex differences in insulin sensitivity and insulin response with increasing age in black South African men and women.
Goedecke JH; George C; Veras K; Peer N; Lombard C; Victor H; Steyn K; Levitt NS
Diabetes Res Clin Pract; 2016 Dec; 122():207-214. PubMed ID: 27889690
[TBL] [Abstract][Full Text] [Related]
7. HOMA-beta in the UKPDS and ADOPT. Is the natural history of type 2 diabetes characterised by a progressive and inexorable loss of insulin secretory function? Maybe? Maybe not?
Reaven GM
Diab Vasc Dis Res; 2009 Apr; 6(2):133-8. PubMed ID: 20368203
[No Abstract] [Full Text] [Related]
8. Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy.
Bellia A; Rizza S; Lombardo MF; Donadel G; Fabiano R; Andreadi K; Quon MJ; Sbraccia P; Federici M; Tesauro M; Cardillo C; Lauro D
Atherosclerosis; 2012 Jul; 223(1):197-203. PubMed ID: 22658255
[TBL] [Abstract][Full Text] [Related]
9. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
10. Early insulin treatment in type 2 diabetes: what are the pros?
Meneghini LF
Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S266-9. PubMed ID: 19875562
[No Abstract] [Full Text] [Related]
11. Managing postprandial glucose levels in patients with diabetes.
Tenzer-Iglesias P; Brunton S
J Fam Pract; 2008 Jan; 57(1 Suppl Managing):S17-24. PubMed ID: 18662529
[No Abstract] [Full Text] [Related]
12. Differences in β-cell function and insulin secretion in Black vs. White obese adolescents: do incretin hormones play a role?
Michaliszyn SF; Lee S; Bacha F; Tfayli H; Farchoukh L; Mari A; Ferrannini E; Arslanian S
Pediatr Diabetes; 2017 Mar; 18(2):143-151. PubMed ID: 26799689
[TBL] [Abstract][Full Text] [Related]
13. Similar weight-adjusted insulin secretion and insulin sensitivity in short-duration late autoimmune diabetes of adulthood (LADA) and type 2 diabetes: Action LADA 9 [corrected].
Juhl CB; Bradley U; Holst JJ; Leslie RD; Yderstraede KB; Hunter S;
Diabet Med; 2014 Aug; 31(8):941-5. PubMed ID: 24628669
[TBL] [Abstract][Full Text] [Related]
14. Anti-Diabetic Activities of Gastrodia elata Blume Water Extracts Are Mediated Mainly by Potentiating Glucose-Stimulated Insulin Secretion and Increasing β-Cell Mass in Non-Obese Type 2 Diabetic Animals.
Yang HJ; Kim MJ; Kwon DY; Kim DS; Lee YH; Kim JE; Park S
Nutrients; 2016 Mar; 8(3):161. PubMed ID: 26978400
[TBL] [Abstract][Full Text] [Related]
15. Defining and characterizing the progression of type 2 diabetes.
Fonseca VA
Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S151-6. PubMed ID: 19875543
[No Abstract] [Full Text] [Related]
16. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.
Muscelli E; Mari A; Casolaro A; Camastra S; Seghieri G; Gastaldelli A; Holst JJ; Ferrannini E
Diabetes; 2008 May; 57(5):1340-8. PubMed ID: 18162504
[TBL] [Abstract][Full Text] [Related]
17. Easing the transition to insulin therapy in people with type 2 diabetes.
Blonde L
Diabetes Educ; 2007; 33 Suppl 7():232S-240S. PubMed ID: 17656739
[No Abstract] [Full Text] [Related]
18. Glycaemic efficacy of canagliflozin is largely independent of baseline β-cell function or insulin sensitivity.
Matthews DR; Zinman B; Tong C; Meininger G; Polidori D
Diabet Med; 2016 Dec; 33(12):1744-1747. PubMed ID: 26600115
[No Abstract] [Full Text] [Related]
19. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
[TBL] [Abstract][Full Text] [Related]
20. Effect of combining rosiglitazone with either metformin or insulin on β-cell mass and function in an animal model of Type 2 diabetes characterized by reduced β-cell mass at birth.
Holloway AC; Hettinga BP; Gerstein HC
J Diabetes; 2011 Mar; 3(1):74-81. PubMed ID: 21040499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
